Detalhe da pesquisa
1.
Once-daily dolutegravir versus darunavir plus cobicistat in adults at the time of primary HIV-1 infection: the OPTIPRIM2-ANRS 169 randomized, open-label, Phase 3 trial.
J Antimicrob Chemother
; 77(9): 2506-2515, 2022 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35762503
2.
Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients.
AIDS
; 20(2): F1-7, 2006 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-16511406
3.
HIV type 2 demyelinating encephalomyelitis.
Clin Infect Dis
; 42(11): e89-91, 2006 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16652302
4.
Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial.
Lancet Infect Dis
; 15(4): 387-96, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25701561
5.
First-line use of enfuvirtide-containing HAART regimen with dramatic clinical and immunological improvement in three cases.
AIDS
; 20(3): 471-3, 2006 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-16439888
6.
Short communication: evidence of HIV type 1 complex and second generation recombinant strains among patients infected in 1997-2007 in France: ANRS CO06 PRIMO Cohort.
AIDS Res Hum Retroviruses
; 26(6): 645-51, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20560794